Searched for
WEIGHT LOSS GLENMARK
The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Alkem Labs CEO Vikas Gupta may exit companyAlkem Labs, a leading Indian drug maker, is set for a top management change. Vikas Gupta, the CEO for nearly three years, is expected to de...
- Novo Nordisk’s weight-loss drug patent loss sparks a ‘gold rush’ for generic drugmakersIndia's weight-loss drug market is seeing a major shift. Generic versions of Novo Nordisk's semaglutide are now available at lower prices. ...
- GLP-1 impact: Jefferies sees these 3 stocks as winners in the race for Ozempic, Wegovy genericsIndian drug makers are launching affordable generic Semaglutide, the active ingredient in popular weight-loss drugs. Sun Pharma, Lupin, and...
- Centre steps up oversight on GLP-1 drugs amid concerns over 'improper' practicesIndia's drug regulator is increasing oversight of GLP-1 weight loss drugs. Inspections across 49 entities revealed violations like unauthor...
- Rs 12,000 crore magic pill race begins to shrink India's pot bellies. Which pharma stocks will win GLP-1 war?India's GLP-1 market is set for a massive boom. Following patent expiry, generic versions of semaglutide are launching at significantly low...
- Indian drugmakers flood market with cheaper versions of Novo's Ozempic, WegovyIndian drugmakers have launched affordable generic versions of popular diabetes and weight-loss drugs. This move significantly reduces trea...
- GLP-1 rush: Pharma, food firms eye tie-ups for weight-loss boomAffordable weight-loss jabs are here. Drugmakers and food companies are partnering. They will offer special nutrition products. These are f...
- Alkem Laboratories launches semaglutide in India at Rs 450 per week, eyes booming weight-loss marketAlkem Laboratories has launched a new semaglutide injection in India. This drug targets the growing diabetes and weight loss market. It is ...
- Natco, Eris Life to launch slimming shots in both Vial and Pen formatsNatco Pharma and Eris Lifesciences are launching generic semaglutide weight-loss injections. The companies are introducing both vial and pe...
- Weight is over! Pharma stocks jump up to 4% as patent for Ozempic's key ingredient expires; what lies ahead?Pharma stocks rose up to 4% as Novo Nordisk’s semaglutide patent nears expiry, raising expectations of cheaper generics in India. Strong gr...
- Glenmark set to join peers in 'Semaglutide' pushGlenmark Pharmaceuticals is set to launch affordable versions of the popular anti-diabetes and obesity drug semaglutide. This move escalate...
- Can Zaynich do for Wockhardt what Ozempic did for Novo Nordisk?Wockhardt's Zaynich antibiotic surged stock by 75%. CEO Habil Khorakiwala cited its uniqueness; phase three trials end this fiscal year. Co...
- India to make drugs for diabetes, obesity under PLI by 2026, says reportIndia plans to incentivize local manufacturing of GLP-1 drugs, crucial for treating diabetes and obesity, starting in 2026, as per a govern...
- Ozempic frenzy lures rich Indians to brave the gray marketPeople are going to great lengths to obtain popular weight-loss drugs. They are stashing injectables in their carry-on luggage, buying coun...
- Pharma may see a price war in good news for diabeticsGlenmark launches a drug at almost half the price of those offered by rivals.
- Glenmark Pharma launches anti-diabetes drug Remogliflozin in IndiaGlenmark said it will commercialise Remogliflozin in India under the brand names 'Remo' and 'Remozen'.
- Market Now: Nifty Pharma in green; Dr Reddy's Labs zooms nearly 8%The Nifty Pharma index was trading 2.41 per cent up at 9,073 around 9.45 am (IST).
- Brokers' call: ITC, Infosys, pharmaITC’s cigarette business has delivered consistent high teens profit growth over the past six years, despite rising taxes.
Load More
